HealthEquity (HQY) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
4 Dec, 2025Executive summary
Achieved strong year-over-year growth in Q3 fiscal 2026: revenue up 7% to $322.2M, net income up 806% to $51.7M, adjusted EBITDA up 20% to $141.8M, and gross margin up to 71%.
Administered 10.1 million HSAs with $34.4 billion in assets and 7.2 million complementary CDBs as of October 31, 2025, totaling 17.3 million accounts, a 5% year-over-year increase.
Launched a new direct HSA enrollment platform targeting ACA bronze plan participants, enhancing digital experience and expanding market reach.
Early adoption of the HealthEquity Marketplace platform, including GLP-1 weight loss support, shows positive member engagement and retention.
Acquired the BenefitWallet HSA portfolio, adding 616,000 HSAs and $2.7 billion in assets.
Financial highlights
Q3 revenue rose 7% year-over-year to $322.2M; service revenue $120.3M, custodial revenue $159.1M, interchange revenue $42.8M.
Gross profit for Q3 was $228.1M with a 71% gross margin, up from 66% last year.
Net income for Q3 was $51.7M ($0.59/share), up 806% year-over-year due to a prior-year legal settlement; non-GAAP net income up 26% to $87.7M ($1.01/share).
Adjusted EBITDA was $141.8M (44% margin), up 20% year-over-year.
Nine-month revenue was $978.8M (up 10%), GAAP net income $165.5M ($1.88/share), non-GAAP net income $268.1M ($3.05/share), and adjusted EBITDA $433.1M (44% margin).
Outlook and guidance
Fiscal 2026 revenue expected between $1.302B and $1.312B.
GAAP net income projected at $197M–$205M ($2.24–$2.33/share); non-GAAP net income $341M–$348M ($3.87–$3.95/share).
Adjusted EBITDA guidance raised to $555M–$565M.
Service, custodial, and interchange revenue expected to grow with account and HSA investment increases.
Corporate income tax payments for fiscal 2026 and 2027 expected to be significantly reduced due to new tax legislation.
Latest events from HealthEquity
- Record HSA and revenue growth, margin expansion, and raised guidance signal strong momentum.HQY
Q4 202617 Mar 2026 - Q1 saw double-digit growth, record HSA assets, and upgraded full-year guidance after a major acquisition.HQY
Q1 202531 Jan 2026 - Revenue up 23%, net income up 239%, and $300M buyback announced for Q2 FY25.HQY
Q2 202522 Jan 2026 - CEO transition to Scott Cutler set for January 2025, with strong growth and innovation focus.HQY
Investor Update14 Jan 2026 - Digital innovation, AI, and margin expansion fuel strong HSA growth and robust financial outlook.HQY
44th Annual J.P. Morgan Healthcare Conference14 Jan 2026 - Revenue up 21% with record HSA asset growth, strong guidance, and expanding market potential.HQY
Q3 202511 Jan 2026 - Record HSA growth, tech innovation, and legislative momentum fuel continued market leadership.HQY
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Record revenue and HSA growth drive strong FY25 results and positive FY26 outlook.HQY
Q4 202526 Dec 2025 - Strong financial results, new CEO, and robust governance drive key proxy proposals.HQY
Proxy Filing1 Dec 2025